The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

Weight-loss drugs like Ozempic may decrease your risk of developing 42 health conditions, but increase your chance of ...

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study ...

Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.

A safety committee will review all evidence from trials and studies to shed more light on the potential risk of NAION.

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Researchers have found links to multiple new benefits – and new side effects – in a study of weight-loss drugs such as ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

"There was an increased risk of gastrointestinal disorders, hypotension, syncope (low blood pressure), arthritic disorders, ...